MEET OUT RESIDENTS

Synobody

Identifies nanobodies that suits any purpose by way of screening their vast synthetic library

At Synobody we wish to provide nanobodies to research groups and companies across the world. By way of screening from our vast synthetic library through multiple affinity panning rounds and ELISA validation we can identify nanobodies that suits any purpose. Our method thus allows us to circumvent expensive and time consuming lama immunisation, giving Synobody an advantage over other providers.

In doing so, we hope to minimize the financial gap between researchers and nanobody immunolabeling.